PGx201 Community: Beyond the Certification Training is OPEN!

Earn a Certificate in Pharmacogenomics

Facilitating the training are Dan Krinsky, BS, MS, RPh and Sue Paul, RPh, PGx101 Co-Founders.
This program enables attendees to learn by using real genetic data in highly interactive exercises.

Earn 20 ACPE accredited continuing education credit hours

Activity Description
The Test2Learn™ Community-based Pharmacogenomics Certificate Program teaches the principles of pharmacogenomics as well as its practical implications in disease states such as cardiology, oncology, neurology and infectious diseases, among others. It trains pharmacists to decipher genetic tests, translate that information, and make appropriate recommendations for the patient (including collection of DNA samples) interpretation of patient results, and counseling and collaboration with prescribers to help optimize patient medication regimens.

The 20-hour ACPE-accredited certificate program enables students to learn by using real genetic data in highly-interactive exercises with an optional activity for learners to undergo personal genomic testing. The Certificate Program is comprised of:

  • 12 hours of home study
  • 8 hours of live training

The target audience for the certificate program is pharmacists in all practice settings including community, ambulatory care, inpatient, professional associations, and academia. While the program is primarily designed for pharmacists, student pharmacists and non-pharmacists interested in pharmacogenomics are also welcome to complete the program.

Successful completion of the live seminar component involves passing the final exam with a grade of 80 percent or higher and demonstrating proficiency in diagnostic testing techniques. Successful completion of this component will result in 8.0 contact hours of continuing pharmacy education credit. Successful completion of the self-study component involves passing the self-study assessment questions with a grade of 80 percent or higher and will result in 12.0 contact hours of continuing pharmacy education. Attendance and participation are required before obtaining CPE credit. Partial credit will not be awarded.

View Learning Objectives »

 

 

Choose Your Course

MINI COURSE

$97

  • Introduction to PGx
  • One hour overview of pharmacogenomics
LEARN MORE

20 HOUR CE PROGRAM

$497

  • 20 hours of ACPE approved CEU delivered as 12 hours online prior to 8 hours LIVE VIRTUALLY. 
  • Upcoming Trainings:

December 3 & 4, 2022

9AM - 1PM EST BOTH DAYS

Sign Me Up

COACHING & CE PROGRAM

$1497

PGx Certificate/20 hours ACPE approved CEU plus Implementation Coaching 

Includes certificate training, CE Program, plus a Toolkit and 1 year personalized coaching to help you implement PGx into your practice.

LEARN MORE

Accreditation
The University of Pittsburgh is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The home study portion of the program is approved for 12 contact hours and the live training is approved for 8 contact hours of continuing pharmacy education credit. Credit is only awarded for completion of the entire 20 contact hour program. Note that the process must be done within 5 days for the live program. After that, upon request, CE can technically be granted for up to 30 days but is more laborious for the participant and provider. After the 30 day expiration, the CE office is unable to grant CE at all per accreditation rules.

 Test2LearnTM Community-based Pharmacogenomics Certificate Program

Activity Type: Practice-based

Target Audience: Pharmacists in all practice settings

About the Continuing Education Provider

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

 

Close

 Get your free copy of the Chart of CPIC Actionable Guidelines for Common Medications